Filing Details

Accession Number:
0001104659-21-065258
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-12 13:00:00
Reporting Period:
2021-05-10
Accepted Time:
2021-05-12 18:01:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1708527 Aziyo Biologics Inc. AZYO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304079 Matthew Ferguson C/O Aziyo Biologics, Inc., 12510
Prosperity Drive, Suite 370
Silver Spring MD 20904
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-05-10 1,300 $11.14 1,300 No 4 P Direct
Class A Common Stock Acquisiton 2021-05-11 1,000 $11.00 2,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.97 to $11.21. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.